A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
- Citation:
- Oncologist vol 24 (5) 589-e160
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 578
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180790, UG1CA189863
- Corr. Author:
- Authors:
- Thorvardur R. Halfdanarson Nathan R. Foster George P. Kim Jeffrey P. Meyers Thomas C. Smyrk Ann E. McCullough Matthew M. Ames Jeffrry P. Jaffe Steven R. Alberts
- Networks:
- LAPS-MN026, METROMIN
- Study
- NCCTG-N064B
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- 4, 6, 31, Clinical Trial Results